Quick Answer
HAEMONETICS CORP reported Operating Income of $221.82 million for fiscal year 2025.
HAEMONETICS CORP Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $221.82M | +34.5% |
| 2024 | $164.88M | +5.7% |
| 2023 | $156.03M | +93.2% |
| 2022 | $80.75M | -10.0% |
| 2021 | $89.75M | -13.2% |
| 2020 | $103.35M | +23.7% |
| 2019 | $83.55M | +48.8% |
| 2018 | $56.16M | +389.8% |
| 2017 | -$19.38M | +55.9% |
| 2016 | -$43.94M | -208.4% |
| 2015 | $40.54M | -12.7% |
| 2014 | $46.43M | -17.7% |
| 2013 | $56.44M | -36.4% |
| 2012 | $88.76M | -19.7% |
| 2011 | $110.55M | +32.7% |
| 2010 | $83.28M | -2.7% |
| 2009 | $85.57M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $67.40M | +14.2% | +15.2% |
| September 30, 2025 | $58.49M | +13.1% | +8.6% |
| June 30, 2025 | $53.87M | +35.5% | -8.7% |
| December 31, 2024 | $59.03M | +28.4% | +14.2% |
| September 30, 2024 | $51.70M | +46.4% | +30.0% |
| June 30, 2024 | $39.76M | -25.9% | -13.5% |
| December 31, 2023 | $45.98M | +6.2% | +30.2% |
| September 30, 2023 | $35.30M | -24.5% | -34.2% |
- HAEMONETICS CORP showed an increase of +34.5% in Operating Income compared to the prior fiscal year.
- Over the 2009–2025 period, HAEMONETICS CORP’s operating income has grown by 159.2% (from $85.57 million to $221.82 million).
- The most recent figure is from HAEMONETICS CORP’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 21, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: